Solid state forms of lucerastat salts and process for preparation thereof
WO2021026307A1
Processes for the preparation of roxadustat and intermediates thereof
WO2021025969A1
Solid state forms of berotralstat
WO2021021775A1
Solid state forms of risdiplam and process for preparation thereof
WO2020232325A1
Solid state forms of tafamidis and salts thereof
WO2020185812A1
Solid state forms of ripretinib
WO2020168144A1
Solid state forms of n-[2-(2-{4-[2-(6,7-dimethoxy-3,4-dihydro-2(lh)- isoquinolinyl)ethyl] phenyl }-2h-tetrazol-5-yl)-4,5-dimethoxyphenyl] -4- oxo-4h-chromene-2-carboxamide and of its mesylate salt
WO2020163431A1
Crystalline solid forms of baricitinib
US2020216427A1
Solid state forms of entrectinib
WO2020139670A1
Solid state forms of balovaptan
WO2020123730A1
Solid state forms of reproxalap
WO2020102302A1
Solid state forms of daprodustat and process for preparation thereof
WO2020086789A1
New crystalline polymorphs of rigosertib sodium
WO2020082061A1
Solid state forms of voclosporin
AU2019344594A1
Injection spring for aged prefilled syringe and auto injector
US10899826B1
Pharmaceutical compositions for an anti-CGRP antagonist antibody
WO2020051282A1
Solid state forms of branaplam and their preparation
WO2020051014A1
Processes for the preparation of tenapanor and intermediates thereof
